Cargando…
In Silico Study Reveals How E64 Approaches, Binds to, and Inhibits Falcipain-2 of Plasmodium falciparum that Causes Malaria in Humans
Plasmodium falciparum malaria, which degrades haemoglobin through falcipain-2 (FP2), is a serious disease killing 445 thousand people annually. Since the P. falciparum’s survival in humans depends on its ability to degrade human’s haemoglobin, stoppage or hindrance of FP2 has antimalarial effects. T...
Autor principal: | Salawu, Emmanuel Oluwatobi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219542/ https://www.ncbi.nlm.nih.gov/pubmed/30401806 http://dx.doi.org/10.1038/s41598-018-34622-1 |
Ejemplares similares
-
Hemoglobin Cleavage Site-Specificity of the Plasmodium falciparum Cysteine Proteases Falcipain-2 and Falcipain-3
por: Subramanian, Shoba, et al.
Publicado: (2009) -
Regulatory Elements within the Prodomain of Falcipain-2, a Cysteine Protease of the Malaria Parasite Plasmodium falciparum
por: Pandey, Kailash C., et al.
Publicado: (2009) -
The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site
por: Machin, Jonathan M., et al.
Publicado: (2019) -
Distinct and stage specific nuclear factors regulate the expression of falcipains, Plasmodium falciparum cysteine proteases
por: Sunil, Sujatha, et al.
Publicado: (2008) -
Quinoline-triazole hybrids inhibit falcipain-2 and arrest the development of Plasmodium falciparum at the trophozoite stage
por: Singh, Anju, et al.
Publicado: (2019)